Literature DB >> 17186189

[Paraneoplastic syndrome in renal cell carcinoma].

J Bedke1, S Buse, M Kurosch, A Haferkamp, D Jäger, M Hohenfellner.   

Abstract

Renal cell carcinoma associated paraneoplastic symptoms include constitutional symptoms as well as specific metabolic and biochemical abnormalities. These are present in up to 40% of patients with renal cell carcinoma during the course of the disease. This report provides information on the most common manifestations and their therapy; some rare variants are also mentioned. The importance of paraneoplasia lies partly in the fact that paraneoplastic symptoms may be the precursor of either primary or recurrent disease. The presence of paraneoplastic manifestations does not necessarily imply a poor prognosis or metastatic disease.

Entities:  

Mesh:

Year:  2007        PMID: 17186189     DOI: 10.1007/s00120-006-1269-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  26 in total

1.  In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets.

Authors:  S Asano; A Okano; K Ozawa; T Nakahata; T Ishibashi; K Koike; H Kimura; Y Tanioka; A Shibuya; T Hirano
Journal:  Blood       Date:  1990-04-15       Impact factor: 22.113

2.  Dermatitis herpetiformis, steatorrhoea, and malignancy.

Authors:  E Gjone; A Nördoy
Journal:  Br Med J       Date:  1970-03-07

3.  Renal cell carcinoma of the kidney and hypertrichosis lanuginosa acquisita.

Authors:  L E Duncan; J D Hemming
Journal:  Br J Urol       Date:  1994-11

Review 4.  Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.

Authors:  R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  A renin-secreting tumor.

Authors:  R Pedrinelli; L Graziadei; S Taddei; M Lenzi; A Magagna; G Bevilacqua; A Salvetti
Journal:  Nephron       Date:  1987       Impact factor: 2.847

6.  Clinical and histological resolution of systemic amyloidosis after renal cell carcinoma removal.

Authors:  G Karsenty; A Ulmann; D Droz; F Carnot; J P Grünfeld
Journal:  Nephron       Date:  1985       Impact factor: 2.847

7.  Hypernephroma and hypertension. Two case reports.

Authors:  T Dahl; I Eide; A Fryjordet
Journal:  Acta Med Scand       Date:  1981

8.  Renal cell carcinoma and systemic amyloidosis: demonstration of AA protein and review of the literature.

Authors:  P R Vanatta; F G Silva; W E Taylor; J C Costa
Journal:  Hum Pathol       Date:  1983-03       Impact factor: 3.466

Review 9.  Cutaneous leukocytoclastic vasculitis and renal cancer: two cases.

Authors:  J P Lacour; J Castanet; C Perrin; A Vitetta; J P Ortonne
Journal:  Am J Med       Date:  1993-01       Impact factor: 4.965

10.  Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis.

Authors:  Hyung L Kim; Arie S Belldegrun; Danielo G Freitas; Matthew H T Bui; Ken-ryu Han; Frederick J Dorey; Robert A Figlin
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450

View more
  3 in total

1.  Difficulties diagnosing psychiatric paraneoplastic syndromes in patients with a psychiatric history: a patient with secondary mania and renal cell carcinoma.

Authors:  Romina Lopez Gaston; Lenia Constantine
Journal:  BMJ Case Rep       Date:  2009-04-07

2.  Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma.

Authors:  Tilman Todenhöfer; Stefan Wirths; Claus Hann von Weyhern; Stefan Heckl; Marius Horger; Joerg Hennenlotter; Arnulf Stenzl; Lothar Kanz; Christian Schwentner
Journal:  BMC Urol       Date:  2012-03-21       Impact factor: 2.264

3.  Stauffer's syndrome as a prominent manifestation of renal cancer: a case report.

Authors:  Georgios P Kranidiotis; Paraskevi T Voidonikola; Meletios K Dimopoulos; Maria I Anastasiou-Nana
Journal:  Cases J       Date:  2009-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.